Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
The role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co-infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant
Anthony, L; Ramin, A; Amit, K; Ashish, B; Phillip, A; Monica, S; Karin, T
(2021), Transpl. Infect. Dis.
DOI: 10.1111/tid.13547
Cancer during pregnancy: A qualitative study of healthcare experiences of Australian women
Stafford, L; Sinclair, M; Gerber, K; Collins, L; Newman, L; Saunders, C; Ives, A; Mason, KD; Peate, M; Lippey, J; Umstad, MP; Shanahan, K; Little, R
(2021), Eur. J. Cancer Care
DOI: 10.1111/ecc.13425
Triphenotypic acute leukaemia: the contribution of multimodality laboratory diagnostic techniques
Leitinger, E; Kuzich, JA; Juneja, S
(2021), Pathology, 678-680
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic
Purtill, D; Hutchins, C; Kennedy, G; McClean, A; Fraser, C; Shaw, PJ; Chiappini, P; Tao, H; Ma, DDF; Kabani, K; Bai, LJ; Greenwood, M; Bajel, A; O'Flaherty, E; Curtis, DJ; Purins, L; Perera, T; Tan, S; Butler, A; Micklethwaite, K; Antonenas, V; Gottlieb, D; Hamad, N
(2021), Transpl. Cell. Ther.
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
Hutchings, M; Morschhauser, F; Iacoboni, G; Carlo-Stella, C; Offner, FC; Sureda, A; Salles, G; Martinez-Lopez, J; Crump, M; Thomas, DN; Morcos, PN; Ferlini, C; Broske, AME; Belousov, A; Bacac, M; Dimier, N; Carlile, DJ; Lundberg, L; Perez-Callejo, D; Umana, P; Moore, T; Weisser, M; Dickinson, MJ
(2021), J. Clin. Oncol., 1959
DOI: 10.1200/JCO.20.03175
Oromandibular parafunction in chronic graft-versus-host disease: novel association and treatment approach
Joshi, P; Kiers, L; Evans, A; Ritchie, D; Szer, J; Cruse, B
(2021), Intern. Med. J., 1950-1953
DOI: 10.1111/imj.15569
Iron deficiency
Pasricha, SR; Tye-Din, J; Muckenthaler, MU; Swinkels, DW
(2021), Lancet, 233-248
WhiMSICAL: A global Waldenstrom's Macroglobulinemia patient-derived data registry capturing treatment and quality of life outcomes
Tohidi-Esfahani, I; Warden, A; Malunis, E; DeNardis, PL; Haurat, J; Black, M; Opat, S; Kee, D; D'Sa, S; Kersten, MJ; Spearing, RL; Palomba, ML; Olszewski, AJ; Harrington, C; Scott, CL; Trotman, J
(2021), Am. J. Hematol., E218-E222
DOI: 10.1002/ajh.26173
Feasibility of early-commencing group-based exercise in allogeneic bone marrow transplantation: the BOOST study
Abo, S; Ritchie, D; Denehy, L; Panek-Hudson, Y; Irving, L; Granger, CL
(2021), Bone Marrow Transplant., 2788-2796
Ibrutinib protects T cells in patients with CLL from proliferation-induced senescence
Davis, JE; Sharpe, C; Mason, K; Tam, CS; Koldej, RM; Ritchie, DS
(2021), J. Transl. Med.
Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients
Davis, JE; Du, K; Ludford-Menting, MJ; Prabahran, A; Wong, E; Huntington, ND; Koldej, RM; Ritchie, DS
(2021), Front. Immunol.
Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant
Lindsay, J; Othman, J; Yong, MK; Ritchie, D; Chee, L; Tay, K; Tio, SY; Kerridge, I; Fay, K; Stevenson, W; Arthur, C; Chen, SCA; Kong, DCM; Greenwood, M; Pergam, SA; Liu, C; Slavin, MA
(2021), Transpl. Infect. Dis.
DOI: 10.1111/tid.13719
Dissection of the bone marrow microenvironment in hairy cell leukaemia identifies prognostic tumour and immune related biomarkers
Koldej, RM; Prabahran, A; Tan, CW; Ng, AP; Davis, MJ; Ritchie, DS
(2021), Sci Rep
Self-reliance or the generosity of others?: autologous versus allogeneic stem cell transplantation in high-risk Hodgkin lymphoma
Koo, RM; Ritchie, D
(2021), Leuk. Lymphoma, 2303-2305
Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation
Prabahran, A; Koldej, R; Chee, L; Wong, E; Ritchie, D
(2021), Leuk. Lymphoma, 1482-1489
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR
Wieduwilt, MJ; Stock, W; Advani, A; Luger, S; Larson, RA; Tallman, M; Appelbaum, F; Zhang, MJ; Bo-Subait, K; Wang, HL; Bhatt, VR; Dholaria, B; Eapen, M; Hamadani, M; Jamy, O; Prestidge, T; Pulsipher, M; Ritchie, D; Rizzieri, D; Sharma, A; Barba, P; Sandmaier, BM; de Lima, M; Kebriaei, P; Litzow, M; Saber, W; Weisdorf, D
(2021), Leukemia, 2076-2085
Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021
Keighley, C; Cooley, L; Morris, AJ; Ritchie, D; Clark, JE; Boan, P; Worth, LJ
(2021), Intern. Med. J., 89-117
DOI: 10.1111/imj.15589
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement
Hamad, N; Ananda-Rajah, M; Gilroy, N; MacIntyre, R; Gottlieb, D; Ritchie, D; Harrison, S; Kennedy, G; Watson, AM; Greenwood, M; Doocey, R; Perera, T; Spencer, A; Wong, E; O'Brien, T; Shaw, P; Conyers, R; Milliken, S; Bardy, P; Larsen, S; Ho, PJ; Lai, H; Bajel, A; Butler, J; Tiley, C; D'Rozario, J; Johnston, A; Cochrane, T; Mills, T; Irving, I; Pullon, H; Purtill, D
(2021), Intern. Med. J., 1321-1323
DOI: 10.1111/imj.15263
Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes
Blombery, P; Fox, LC; Ryland, GL; Thompson, ER; Lickiss, J; McBean, M; Yerneni, S; Hughes, D; Greenway, A; Mechinaud, F; Wood, EM; Lieschke, GJ; Szer, J; Barbaro, P; Roy, J; Wight, J; Lynch, E; Martyn, M; Gaff, C; Ritchie, D
(2021), Haematologica, 64-73
T Cell Fitness and Autologous CAR T Cell Therapy in Haematologic Malignancy
Mehta, PH; Fiorenza, S; Koldej, RM; Jaworowski, A; Ritchie, DS; Quinn, KM
(2021), Front. Immunol.
An atypical case of Epstein-Barr virus-positive plasma cell post-transplant lymphoproliferative disorder successfully treated with adoptive cell therapy
Elliott, J; Avdic, S; Selim, AG; Clancy, L; Atkins, E; Blyth, E; Ritchie, D; Gottlieb, D; Bajel, A
(2021), Br. J. Haematol., 140-143
DOI: 10.1111/bjh.17633
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis
Kennedy, GA; Tey, SK; Buizen, L; Varelias, A; Gartlan, KH; Curley, C; Olver, SD; Chang, KS; Butler, JP; Misra, A; Subramoniapillai, E; Morton, AJ; Durrant, S; Henden, AS; Moore, J; Ritchie, D; Gottlieb, D; Cooney, J; Paul, SK; Hill, GR
(2021), Blood, 1970-1979
International Forum on Transfusion Practices in Haematopoietic Stem-Cell Transplantation: Responses
Solves, P; Lozano, M; Zhiburt, E; Velasco, JA; Perez-Corral, AM; Monsalvo-Saornil, S; Yamazaki, S; Okazaki, H; Selleng, K; Aurich, K; Kruger, W; Buser, A; Holbro, A; Infanti, L; Stehle, G; Pierelli, L; Matteocci, A; Rigacci, L; De Vooght, KMK; Kuball, JHE; Fielding, KL; Westerman, DA; Wood, EM; Cohn, CS; Johnson, A; Koh, MBC; Qadir, D; Cserti-Gazdewich, C; Daguindau, E; Angelot-Delettre, F; Tiberghien, P; Wendel-Neto, S; Fachini, RM; Morton, S; Craddock, C; Lumley, M; Antoniewicz-Papis, J; Halaburda, K; Letowska, M; Dunbar, N
(2021), Vox Sang., E25-E43
DOI: 10.1111/vox.13021
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia
Gordon, SF; Clothier, HJ; Morgan, H; Buttery, JP; Phuong, LK; Monagle, P; Chunilal, S; Wood, EM; Tran, H; Szer, J; Crawford, NW
(2021), Vaccine, 7052-7057
Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience
Vazirani, J; Routledge, D; Snell, GI; Watson, D; Paraskeva, M; Westall, GP; Harrison, SJ
(2021), Transplant. Proc., 296-302
Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program
El Fakih, R; Greinix, H; Koh, M; Shaw, B; Mohty, M; Al Nahedh, M; Saber, W; Kharfan-Dabaja, MA; Perales, MA; Savani, BN; Majhail, NS; Passweg, JR; Sureda, A; Ahmed, SO; Gluckman, E; Riches, M; El-Jawahri, A; Rondelli, D; Srivastava, A; Faulkner, L; Atsuta, Y; Ballen, KK; Rasheed, W; Okamoto, S; Seber, A; Chao, N; Kroger, N; Kodera, Y; Szer, J; Hashmi, SK; Horowitz, MM; Weisdorf, D; Niederwieser, D; Aljurf, M
(2021), Transpl. Cell. Ther.
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy
Orfali, N; Zhang, MJ; Allbee-Johnson, M; Boelens, JJ; Artz, AS; Brunstein, CG; McNiece, IK; Milano, F; Abid, MB; Chee, L; Diaz, MA; Grunwald, MR; Hematti, P; Hsu, JM; Lazarus, HM; Munshi, PN; Prestidge, T; Ringden, O; Rizzieri, D; Riches, ML; Seo, S; Solh, M; Solomon, S; Szwajcer, D; Yared, J; van Besien, K; Eapen, M
(2021), Transpl. Cell. Ther.
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation
Farhadfar, N; Dias, A; Wang, T; Fretham, C; Chhabra, S; Murthy, HS; Broglie, L; D'Souza, A; Gadalla, SM; Gale, RP; Hashmi, S; Al-Homsi, AS; Hildebrandt, GC; Hematti, P; Rizzieri, D; Chee, L; Lazarus, HM; Bredeson, C; Jaimes, EA; Beitinjaneh, A; Bashey, A; Prestidge, T; Krem, MM; Marks, DI; Benoit, S; Yared, JA; Nishihori, T; Olsson, RF; Freytes, CO; Stadtmauer, E; Savani, BN; Sorror, ML; Ganguly, S; Wingard, JR; Pasquini, M
(2021), Transpl. Cell. Ther., 410-422
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
Oran, B; Ahn, KW; Fretham, C; Beitinjaneh, A; Bashey, A; Pawarode, A; Wirk, B; Scott, BL; Savani, BN; Bredeson, C; Weisdorf, D; Marks, DI; Rizzieri, D; Copelan, E; Hildebrandt, GC; Hale, GA; Murthy, HS; Lazarus, HM; Cerny, J; Liesveld, JL; Yared, JA; Yves-Cahn, J; Szer, J; Verdonck, LF; MahmoudAljurf; van der Poel, M; Litzow, M; Kalaycio, M; Grunwald, MR; AngelDiaz, M; Sabloff, M; Kharfan-Dabaja, MA; Majhail, NS; Farhadfar, N; Reshef, R; Olsson, RF; Gale, RP; Nakamura, R; Seo, S; Chhabra, S; Hashmi, S; Farhan, S; Ganguly, S; Nathan, S; TaigaNishihori; Jain, T; VaibhavAgrawal; Bacher, U; Popat, U; Saber, W
(2021), Transpl. Cell. Ther.
Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation
Worel, N; Shaw, BE; Aljurf, M; Koh, M; Seber, A; Weisdorf, D; Schwartz, J; Galeano, S; Kodera, Y; Eldridge, PW; Hashmi, S; Atsuta, Y; Szer, J; Saber, W; Niederwieser, D; Greinix, HT
(2021), Transpl. Cell. Ther.